Blue Bird Corporation is a compelling investment due to its focus on electric school buses and attractive stock valuation despite recent performance setbacks. Read more here.

Blue Bird Corporation (BLBD) recently announced fiscal Q1 results, beating top and bottom-line expectations. While the ...

Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK ...

(NASDAQ:BLUE) lost ~37% in the premarket on Friday after the gene therapy developer announced its plans to become a privately held biotech as part of an M&A agreement with private equity firms Carlyle ...

Blue Bird Corporation (NASDAQ:BLBD), a leading manufacturer of school buses, has been making significant strides in the electric vehicle (EV) market while improving its operational efficiency.

The agreement, which also includes a team of biotech executives, will see Bluebird Bio’s stockholders receive $3.00 per share ...

BofA moved to No Rating on Bluebird Bio (BLUE) after the company announced it has entered a definitive merger agreement under which Carlyle and ...

Delving into Blue Bird's Background Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments ...

School bus company Blue Bird (NASDAQ:BLBD) will be announcing earnings results tomorrow after market hours. Here’s what you need to know. Blue Bird beat analysts’ revenue expectations by 5.3% ...

Electric and low-emission school bus manufacturer Blue Bird Corp. is making another leadership change. The Macon-based public company announced Jan. 23 it will appoint John Wyskiel, a veteran of ...

School bus company Blue Bird (NASDAQ:BLBD) reported Q4 CY2024 results exceeding the market’s revenue expectations , but sales fell by 1.2% year on year to $313.9 million. On the other hand, ...